🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Multiple Sclerosis (MS)

Risk of Progressive Multifocal Leukoencephalopathy Among Patients With Multiple Sclerosis Exposed to Zeposia NCT07732907n/a1 site📍 Lawrenceville Bristol-Myers Squibb · Tests: Ozanimod Prepare the Mind: Can Coaching in Goal-directed Behaviour Increase the Success of Cognitive Rehabilitation in People With MS? NCT07225868NA3 sites📍 Buffalo📍 Leiden📍 Rheinfelden Universiteit Leiden · Tests: Conscientiousness Coaching Before Cognitive Rehabilitation, Sham Intervention Before Cognitive Rehabilitation Blood Flow Restriction And Veterans With MS NCT05433103NA1 site📍 Aurora VA Office of Research and Development · Tests: Low-Load Exercise with Blood Flow Restriction, Low-Load Exercise Control Group Impact of TTNS on Bladder Symptoms Among People With MS, A RCT NCT06341673NA1 site📍 Khobar Hawra Al-Dandan · Tests: Active Transcutaneous Electrical Nerve Stimulation (TENS), Sham Transcutaneous Electrical Nerve Stimulation (TENS) Spinal Cord Lesion Detection in Multiple Sclerosis Using Novel MRI Sequences NCT04819737NA1 site📍 Basel University Hospital, Basel, Switzerland · Tests: SC MRI, patient questionnaire Smoldering Inflammation in MS NCT06591429n/a1 site📍 St Louis Washington University School of Medicine · Tests: Radiotracer [11C]-CS1P1, Radiotracer [11C]-DPA-713, anti-CD20 MS treatment, Radiotracer [12F]-FDG Body Awareness, Trunk Stability, and Arm Function in MS NCT07151534n/a1 site📍 Ankara Hacettepe University Repetitive Transcranial Magnetic Stimulation (rTMS) in MS Induced Spastic Paraparesis NCT07159789NA1 site📍 Gatineau Clinique Neuro-Outaouais · Tests: Repetitive Transcranial Magnetic Stimulation Identification of Factors Related to UI in Patients With MS and EMG Assessment of PFM Activity NCT07236684n/a1 site📍 Istanbul Artvin Coruh University A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of RO7268489 as Add-on Therapy to Ocrelizumab, in Participants With Progressive Forms of Multiple Sclerosis (MS) NCT07282574Phase 2114 sites📍 Camperdown📍 Kogarah📍 New Lambton Heights Hoffmann-La Roche · Tests: RO7268489, Ocrelizumab, Placebo Molecular Imaging of NET Using [C-11]MRB-PET in MS NCT03207464Phase 1, Phase 21 site📍 Boston Brigham and Women's Hospital · Tests: [C-11]Methylreboxetine Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis NCT07477639Phase 1, Phase 28 sites📍 La Jolla📍 Kansas City📍 Rochester Tr1X, Inc. · Tests: TRX319, Bendamustine A Study Evaluating the Effect of BRIUMVI® (Ublituximab) on Pregnancy and Infant Outcomes in Participants With Multiple Sclerosis (MS) NCT06433765n/a1 site📍 Wilmington TG Therapeutics, Inc. · Tests: No intervention Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy Volunteers NCT05395624Phase 1, Phase 23 sites📍 San Francisco📍 Stanford📍 Jacksonville Ashvattha Therapeutics, Inc. · Tests: 18F-OP-801 Cooling During Inpatient Rehabilitation in Persons With MS NCT07852156NA1 site📍 Valens Klinik Valens · Tests: Wearing a cooling vest during intensive, active training sessions, Control Safety and Efficacy Study of Fingolimod in Taiwanese Adults (≥ 20years) With Relapsing Remitting Multiple Sclerosis NCT04480853Phase 46 sites📍 Kaohsiung City📍 Taichung📍 Tainan Novartis Pharmaceuticals · Tests: Fingolimod Effect of Corticosteroids on Inflammation at the Edge of Acute Multiple Sclerosis Plaques NCT02784210Phase 21 site📍 Bethesda National Institute of Neurological Disorders and Stroke (NI… · Tests: Methylprednisolone, Prednisone Fatigue Investigation Using Digital Outcomes NCT07783074n/a6 sites📍 Basel📍 Zurich📍 Zurich Liliana Barrios Multiple Sclerosis Treatment With Autologous Hematopoietic Stem Cell Transplantation in the Netherlands NCT06567197n/a2 sites📍 Amsterdam📍 Nieuwegein Amsterdam UMC, location VUmc Comparison of Digital Biomarkers in Subjects With Radiologically Isolated Syndrome (RIS) and Multiple Sclerosis (MS) Patients With Clinically Normal Neurological Examination NCT07135752NA1 site📍 Nice Centre Hospitalier Universitaire de Nice · Tests: Precision assessment Care in Multiple Sclerosis (MS) NCT07011914n/a6 sites📍 Birmingham📍 San Francisco📍 Aurora NYU Langone Health Exploring the Utility of [18F]3F4AP for Demyelination Imaging NCT06999434Phase 11 site📍 New Haven Yale University · Tests: [ 18F]3F4AP, [18F]MK6240, [11C]PIB MRI-Based Lesion Differentiation in Older Patients With Multiple Sclerosis NCT07444047n/a1 site📍 Oslo Oslo University Hospital Wearable Focal Vibration Therapy on Upper Extremity Function of People With Multiple Sclerosis: A Pilot Study NCT07376772NA2 sites📍 Gainesville📍 Gainesville University of Florida · Tests: wearable focal vibration therapy REAL-MS: Observational Database Study of AHSCT and MS Therapies NCT07899502n/a3 sites📍 London📍 London📍 London Imperial College London · Tests: Autologous haematopoietic stem cell transplantation (AHSCT), High-efficacy disease-modifying therapy (HE-DMT) A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis NCT07225504Phase 3296 sites📍 Birmingham📍 Phoenix📍 Phoenix Novartis Pharmaceuticals · Tests: Remibrutinib (blinded), Placebo, Remibrutinib (Open label) Glucose Consumption in MS Using [F-18]FDG-PET NCT07087106Phase 41 site📍 Boston Brigham and Women's Hospital · Tests: [F-18]FDG Technological Balance and Gait Rehabilitation in Patients With Multiple Sclerosis. NCT05983809NA1 site📍 Roma Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Tests: Technological rehabilitation A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis NCT07067463Phase 376 sites📍 Pheonix📍 Scottsdale📍 West Hollywood Zenas BioPharma (USA), LLC · Tests: Orelabrutinib, Placebo The MS-CEBA Study: Determining Cognitive, Energetic, Behavioural and Affective (CEBA) Profiles in Multiple Sclerosis NCT06016309n/a1 site📍 Groningen University Medical Center Groningen · Tests: There is no intervention.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy